AN OPEN-LABEL EXTENSION OF TWO PLACEBO-CONTROLLED STUDIES OF CARISBAMATE AS ADJUNCTIVE TREATMENT OF PARTIAL ONSET SEIZURES IN ADULTS: 18-MONTH UPDATE

被引：0
|
作者：
Halford, J. [1 ]
Kalviainen, R. [2 ]
Ben-Menachem, E. [3 ]
Schmitt, J. [4 ]
Wiegand, F. [5 ]
Novak, G. [4 ]
机构：
[1] Med Univ S Carolina, Charleston, SC USA
[2] Kupio Univ Hosp, Kupio Epilepsy Ctr, Kuopio, Finland
[3] Univ Gothenburg, Sahlgrenska Acad, Inst Clin Neurosci & Physiol, Gothenburg, Sweden
[4] Johnson & Johnson Pharmaceut Res & Dev LLC, Raritan, NJ USA
[5] Johnson & Johnson Pharmaceut Serv LLC, Raritan, NJ USA
来源：
EPILEPSIA | 2009年 / 50卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：62 / 62
页数：1
相关论文
共 50 条
  • [31] Evaluation of Long-Term Treatment with Lacosamide for Partial-Onset Seizures: A Pooled Analysis of Open-Label Extension Trials
    Rosenfeld, William
    Husain, Aatif
    Rosenow, Felix
    McShea, Cindy
    Isojarvi, Jouko
    Doty, Pamela
    [J]. NEUROLOGY, 2012, 78
  • [32] Alefacept with methotrexate for treatment of psoriatic arthritis: Open-label extension of a randomized, double-blind, placebo-controlled study
    Mease, Philip J.
    Reich, Kristian
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2009, 60 (03) : 402 - 411
  • [33] Vigabatrin with hormonal treatment versus hormonal treatment alone (ICISS) for infantile spasms: 18-month outcomes of an open-label, randomised controlled trial
    O'Callaghan, Finbar J. K.
    Edwards, Stuart W.
    Alber, Fabienne Dietrich
    Borja, Mario Cortina
    Hancock, Eleanor
    Johnson, Anthony L.
    Kennedy, Colin R.
    Likeman, Marcus
    Lux, Andrew L.
    Mackay, Mark T.
    Mallick, Andrew A.
    Newton, Richard W.
    Nolan, Melinda
    Pressler, Ronit
    Rating, Dietz
    Schmitt, Bernhard
    Verity, Christopher M.
    Osborne, John P.
    [J]. LANCET CHILD & ADOLESCENT HEALTH, 2018, 2 (10): : 715 - 725
  • [34] Efficacy and safety of lacosamide as first add-on or later adjunctive treatment for uncontrolled partial-onset seizures: A multicentre open-label trial
    Zadeh, Wendy Waldman
    Escartin, Antonio
    Byrnes, William
    Tennigkeit, Frank
    Borghs, Simon
    Li, Ting
    Dedeken, Peter
    De Backer, Marc
    [J]. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2015, 31 : 72 - 79
  • [35] Safety and efficacy of adjunctive lacosamide among patients with partial-onset seizures in a long-term open-label extension trial of up to 8 years
    Rosenfeld, William
    Fountain, Nathan B.
    Kaubrys, Gintaras
    Ben-Menachemd, Elinor
    McShea, Cindy
    Isojarvi, Jouko
    Doty, Pamela
    [J]. EPILEPSY & BEHAVIOR, 2014, 41 : 164 - 170
  • [36] Vortioxetine in children and adolescents with major depressive disorder: 6-month and 18-month open-label, flexible-dose, long-term extension studies
    DelBello, Melissa P.
    Findling, Robert L.
    Huss, Michael
    Necking, Oscar
    Petersen, Maria L.
    Schmidt, Simon N.
    Rosen, Monika
    [J]. EUROPEAN CHILD & ADOLESCENT PSYCHIATRY, 2024,
  • [37] Efficacy and safety of perampanel in a randomized, placebo-controlled trial with an open-label extension in patients with seizures associated with Lennox-Gastaut syndrome (LGS)
    Porter, Brenda
    Kira, Ryutaro
    Lee, Jeehun
    Aeby, Alec
    Patten, Anna
    Ngo, Leock
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2023, 455
  • [38] Safety and efficacy of adjunctive lacosamide in Chinese and Japanese adults with epilepsy and focal seizures: A long-term, open-label extension of a randomized, controlled trial
    Inoue, Yushi
    Liao, Weiping
    Wang, Xuefeng
    Du, Xinlu
    Tennigkeit, Frank
    Sasamoto, Hiroshi
    Osakabe, Toru
    Hoshii, Naoki
    Yuen, Nancy
    Hong, Zhen
    [J]. EPILEPSY RESEARCH, 2021, 176
  • [39] SEIZURE FREEDOM AND PATIENT RETENTION WITH ADJUNCTIVE ESLICARBAZEPINE ACETATE THERAPY IN ADULTS WITH REFRACTORY PARTIAL SEIZURES DURING THREE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIALS WITH 1-YEAR, OPEN-LABEL EXTENSIONS
    Maia, J.
    Ben-Menachem, E.
    Elger, C.
    Gil-Nagel, A.
    Nunes, T.
    Soares-da-Silva, P.
    [J]. EPILEPSIA, 2010, 51 : 149 - 149
  • [40] Hexasodium fytate for the treatment of calciphylaxis: a randomised, double-blind, phase 3, placebo-controlled trial with an open-label extension
    Sinha, Smeeta
    Nigwekar, Sagar U.
    Brandenburg, Vincent
    Gould, Lisa J.
    Serena, Thomas E.
    Moe, Sharon M.
    Aronoff, George R.
    Chatoth, Dinesh K.
    Hymes, Jeffrey L.
    Carroll, Kevin J.
    Alperovich, Gabriela
    Keller, Laurence H.
    Perello, Joan
    Gold, Alex
    Chertow, Glenn M.
    [J]. ECLINICALMEDICINE, 2024, 75
12345